Federal Register / Vol. 88, No. 191 / Wednesday, October 4, 2023 / Notices 68639 

VII. Agency Contacts 

1. Questions on the programmatic 

issues may be directed to: 

Applicant’s Area Diabetes Consultant: 

https://www.ihs.gov/diabetes/aboutus/area-diabetes-consultants-adc/, 

IHS Division of Diabetes Treatment 

and Prevention, 5600 Fishers Lane, 

Mailstop: 08N34A, Rockville, MD 

20857, Phone: (844) 447–3387, Fax: 

(301) 594–6213, Email: 

diabetesprogram@ihs.gov and sdpi@

ihs.gov, Division of Diabetes website: 

https://www.ihs.gov/diabetes/ and 

https://www.ihs.gov/sdpi/ 

2. Questions on awards management 

and fiscal matters may be directed to: 

Indian Health Service, Division of 

Grants Management, 5600 Fishers 

Lane, Mail Stop: 09E70, Rockville, 

MD 20857, Email: DGM@ihs.gov. 

3. For technical assistance with 

Grants.gov, please contact the 

Grants.gov help desk at (800) 518–4726, 

or by email at support@grants.gov. 

4. For technical assistance with 

GrantSolutions, please contact the 

GrantSolutions help desk at (866) 577– 

0771, or by email at help@

grantsolutions.gov. 

VIII. Other Information 

The Public Health Service strongly 

encourages all grant, cooperative 

agreement, and contract recipients to 

provide a smoke-free workplace and 

promote the non-use of all tobacco 

products. In addition, Public Law 103– 

227, the Pro-Children Act of 1994, 

prohibits smoking in certain facilities 

(or in some cases, any portion of the 

facility) in which regular or routine 

education, library, day care, health care, 

or early childhood development 

services are provided to children. This 

is consistent with the HHS mission to 

protect and advance the physical and 

mental health of the American people. 

Roselyn Tso, 

Director, Indian Health Service. 

[FR Doc. 2023–22057 Filed 10–3–23; 8:45 am] 

BILLING CODE 4166–14–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; 

Developing Digital Therapeutics for 

Substance Use Disorders. 

Date: November 14, 2023. 

Time: 1:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Health, 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Jenny Raye Browning, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, Division of Extramural 

Research, National Institute on Drug Abuse, 

NIH, 301 North Stonestreet Avenue, MSC 

6021, Bethesda, MD 20892, (301) 443–4577, 

jenny.browning@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.277, Drug Abuse Scientist 

Development Award for Clinicians, Scientist 

Development Awards, and Research Scientist 

Awards; 93.278, Drug Abuse National 

Research Service Awards for Research 

Training; 93.279, Drug Abuse and Addiction 

Research Programs, National Institutes of 

Health, HHS) 

Dated: September 29, 2023. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–22045 Filed 10–3–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Board of Scientific 

Counselors, National Cancer Institute, 

November 13, 2023, 10 a.m. to 

November 14, 2023, 1:45 p.m., National 

Institute of Health, Building 31, C Wing, 

6th Floor, Conference Room C, 9000 

Rockville Pike, Bethesda, MD 20892, 

which was published in the Federal 

Register on September 28, 2023, FR Doc 

2023–21147, 88 FR 66861. 

This meeting notice is being amended 

to change the meeting type from 

partially closed to closed. Due to 

scheduling difficulties, there will no 

longer be an open session of the 

meeting. The meeting is closed to the 

public. 

Dated: September 28, 2023. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–21974 Filed 10–3–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Human Genome Research 

Institute; Notice of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Human 

Genome Research Institute Special Emphasis 

Panel; High Quality Reference Genomes 

(HQRG). 

Date: November 29, 2023. 

Time: 3:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Human Genome Research 

Institute, National Institutes of Health, 6700B 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Rudy O. Pozzatti, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Human Genome Research 

Institute, National Institutes of Health, 6700B 

Rockledge Drive, MSC 6908, Bethesda, MD 

20892, (301) 402–8739, pozzattr@

mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.172, Human Genome 

Research, National Institutes of Health, HHS) 

Dated: September 28, 2023. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–21889 Filed 10–3–23; 8:45 am] 

BILLING CODE 4140–01–P 


lotter on DSK11XQN23PROD with NOTICES1